<?xml version="1.0" encoding="utf-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd"><url><loc>https://www.gcimagazine.com/brands-products/hair-care/news/22968202/loral-backs-rnai-drug-developer-in-80m-bet-on-the-future-convergence-of-beauty-and-health</loc><news:news><news:publication><news:name>Global Cosmetic Industry</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-04T13:32:32.000Z</news:publication_date><news:title>L&apos;Oréal Backs RNAi Drug Developer in $80M Bet on the Future Convergence of Beauty and Health</news:title></news:news><image:image><image:loc>https://img.gcimagazine.com/mindful/allured/workspaces/default/uploads/2026/06/adobestock-515197372.5rIgNcxizd.jpg?auto=format%252Ccompress&amp;q=70</image:loc><image:caption>OliX is currently developing RNAi candidates for hair loss, hypertrophic scars, metabolic disorders and other conditions, leveraging its proprietary OASIS delivery platform.</image:caption></image:image></url><url><loc>https://www.gcimagazine.com/brands-products/skin-care/news/22968200/from-juice-in-junk-out-to-exosomes-karen-behnkes-beauty-crush-signals-clean-beautys-next-chapter</loc><news:news><news:publication><news:name>Global Cosmetic Industry</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-04T13:06:08.000Z</news:publication_date><news:title>From &apos;Juice In, Junk Out&apos; to Exosomes: Karen Behnke&apos;s Beauty Crush Signals Clean Beauty&apos;s Next Chapter</news:title></news:news><image:image><image:loc>https://img.gcimagazine.com/mindful/allured/workspaces/default/uploads/2026/06/beauty-crush-skincare-founder-karen-behnke.Cp4PTEOjZr.jpg?auto=format%252Ccompress&amp;q=70</image:loc><image:caption>With the launch of Beauty Crush Skincare, Karen Behnke appears to be betting that beauty consumers want something more than clean—they want clinically driven regenerative biotechnology.</image:caption></image:image><image:image><image:loc>https://img.gcimagazine.com/mindful/allured/workspaces/default/uploads/2026/06/beauty-crush-skincare-triple-action-exocellular-serum-and-moisturizer.jpdQJMRSWX.jpg?auto=format%252Ccompress&amp;q=70</image:loc><image:caption>Beauty Crush&amp;apos;s messaging reflects a transition in clean beauty. While sustainability, organic agriculture and clean ingredient sourcing remain central to the brand story, the lead narrative is regenerative biotechnology.</image:caption></image:image></url><url><loc>https://www.gcimagazine.com/retail/brick-and-mortar/news/22968057/9-drivers-of-ultas-q1-growth-and-a-times-square-flagship-teaser</loc><news:news><news:publication><news:name>Global Cosmetic Industry</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-02T20:24:15.000Z</news:publication_date><news:title>9 Drivers of Ulta’s Q1 Growth (and a Times Square Flagship Teaser)</news:title></news:news><image:image><image:loc>https://img.gcimagazine.com/mindful/allured/workspaces/default/uploads/2026/06/adobestock-1418339326-editorial-use-only.UyDldgaMHo.jpg?auto=format%252Ccompress&amp;q=70</image:loc><image:caption>The retailer also demonstrated improving profitability, with gross margin expanding to 40.1% from 39.1% a year ago, reflecting stronger merchandise margins and lower inventory shrink.</image:caption></image:image></url></urlset>